Preliminary Efficacy of Tocilizumab Treatment in the Patients with COVID-19

Preliminary Efficacy of Tocilizumab Treatment in the Patients with COVID-19

Abstract Background Interleukin-6 (IL-6) was considered to be with the severity and mortality in COVID-19 patients, which implies a potential therapeutic target for treatment. We aimed to evaluate the safety and initial efficacy of Tocilizumab treatment for COVID-19 patients. Methods In the retrospe...

Full description

Bibliographic Details
Main Authors: Yu Chen, Xijing Zhang
Format: Article
Language:English
Published: Springer 2021-04-01
Series:Intensive Care Research
Subjects:
COVID-19
Tocilizumab
preliminary efficacy
safety
Online Access:https://doi.org/10.2991/icres.k.210406.001

Internet

https://doi.org/10.2991/icres.k.210406.001

Similar Items